NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 104

DEA Cultivation Clinical Trials Policy 104

Cannabis Law Report

SEPTEMBER 1, 2021

Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. Court Dismisses DEA Marijuana Rescheduling Case, But Judge Says Cannabis Reclassification May Be Coming Anyway. Marijuana Moment reports.

DEA 109

DEA Marijuana Policy Cannabis 109

Cannabis Law Report

MAY 6, 2023

Including Bright Green, eight entities are now registered with the DEA as federally licensed cannabis “bulk manufacturers.” MJ Biz report The U.S. Drug Enforcement Administration has officially registered publicly traded Bright Green Corp. as a federally licensed cannabis cultivator and product manufacturer.

DEA 52

DEA Cultivation Cannabis 52

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

Canna Law Blog

OCTOBER 29, 2020

The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020.

DEA 87

DEA Hemp Extraction Cannabinoids 87

Cannabis Law Report

NOVEMBER 1, 2021

Our position on D8 from hemp was recently confirmed by the DEA in two public announcements- a webinar and a letter. DEA Says “No” ” … The post Is D8 From Hemp a Controlled Substance? DEA Says “No”. See the video and read the letter in this post. first appeared on Kight on Cannabis.

DEA 52

DEA Hemp Cannabis 52

Cannabis Law Report

MARCH 24, 2020

The Notice of Proposed Rulemaking, published in the Federal Register today for public inspection, provides details on the proposed process for administering the new program. The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research.

DEA 80

DEA Marijuana Extraction Strains 80

Cannabis Law Report

AUGUST 12, 2021

Aurum Labs ( [link] ) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration.

DEA 98

DEA Hemp Compliance Compliance 98

Canna Law Blog

AUGUST 24, 2020

On Friday, the Drug Enforcement Administration (“DEA”) released an Interim Final Rule (the “ Rule ”) that, as we discussed , threatens the hemp industry by treating partially processed hemp extract not intended for consumption (also known as “intermediary hemp”) as a Schedule I controlled substance.

DEA 87

DEA THC Sativa Hemp 87

Canna Law Blog

SEPTEMBER 16, 2020

Unfortunately, the Drug Enforcement Administration (DEA) dropped a surprise interim hemp rule a few weeks ago, which took immediate effect and came as a shock to virtually everyone. The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”?

DEA 86

DEA Hemp Extraction Cannabinoids 86

Canna Law Blog

OCTOBER 29, 2020

The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020.

DEA 75

DEA Hemp Extraction Cannabinoids 75

Cannabis Law Report

FEBRUARY 24, 2023

The public will be able to comment for 30 […]

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

NOVEMBER 5, 2021

Cybin Granted DEA Schedule I Manufacturing License. Drug Enforcement Agency (“DEA”). The DEA license is a federal requirement for any investigators who intend to study, produce, analyze or otherwise work with Schedule I controlled substances. The DEA license is for the Company’s research lab in the Boston area.

DEA 52

DEA Research and Development Programs Media 52

Cannabis Law Report

JUNE 14, 2021

Drug Enforcement Administration (DEA) to formally reconsider marijuana’s restrictive federal classification made their case on Thursday to a three-judge panel of the U.S. Marijuana Moment reports. Attorneys for a group of scientists and military veterans seeking to force the U.S. Court of Appeals for the Ninth Circuit.

DEA 97

DEA Marijuana Cannabis Law 97

NORML

JANUARY 12, 2024

The post HHS Releases Unredacted Letter Confirming Agency’s Recommendation to DEA to Reclassify Marijuana to Schedule III appeared first on NORML.

DEA 320

DEA Marijuana Patients Cannabis 320

Canna Law Blog

SEPTEMBER 28, 2020

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 But some have taken their opposition one step further by suing the DEA.

DEA 61

DEA Hemp Agriculture Compliance 61

Cannabis Law Report

MARCH 21, 2020

The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. DEA is making progress to register additional marijuana growers for federally authorized research, and will continue to work with other relevant federal agencies to expedite the necessary next steps.”. “DEA

DEA 97

DEA Marijuana Extraction Programs 97

MassRoots

NOVEMBER 19, 2018

The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. That includes fully legal states like California, where enforcement efforts are generally limited to public lands—namely national forests.

DEA 64

DEA Programs Marijuana Collective 64

WeedAdvisor

AUGUST 28, 2019

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

SpeedWeed

MAY 22, 2021

After years of delays, legal challenges, and obfuscation, the US Drug Enforcement Agency (DEA) finally announced that it would begin evaluating applications for federally-licensed research cannabis cultivators. . In 2019, a federal judge forced the DEA to explain its inaction.

DEA 52

DEA Cultivation Research and Development Cannabis 52

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling. You understand what I’m saying?

DEA 97

DEA Marijuana History Cannabis 97

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

DECEMBER 2, 2019

The Drug Enforcement Administration (DEA) finalized its plans to authorize the cultivation of 3,200,000 grams of marijuana for research purposes next year—a 30 percent increase from 2019’s quota. DEA initially proposed 2020 production quotas in a notice published in the Federal Register in September. DEA Finalizes Plan To Grow 3.2

DEA 59

DEA Cultivation Cannabis Marijuana 59

Greenspoon Marder Cannabis Law Group Blog

AUGUST 26, 2020

Drug Enforcement Administration (“DEA”) published an interim final rule surrounding hemp and hemp derivatives. In effectuating this regulatory change, the DEA has either deliberately ignored the language above, or has simply failed to recognize a linguistic nuance. By: Nabil Rodriguez. Last week on Thursday August 20, 2020, the U.S.

DEA 40

DEA CBD Extraction Hemp 40

Cannabis Law Report

AUGUST 26, 2019

Office of Public Affairs. DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Department of Justice. FOR IMMEDIATE RELEASE. Monday, August 26, 2019.

DEA 59

DEA Access Marijuana Programs 59

Cannabis Law Report

JANUARY 31, 2020

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced the publication of the 2019 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. Press Release. 2019-NDTA-final-01-14-2020_Low_Web-DIR-007-20_2019.

DEA 59

DEA Data Recreational Marijuana 59

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Canna Law Blog

FEBRUARY 16, 2024

Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.

DEA 79

DEA Seed-To-Sale Hemp Concentrates 79

Cannabis Law Report

NOVEMBER 20, 2021

Drug Enforcement Administration (DEA), the Alabama Prescription Drug Monitoring Program maintained by Alabama Department of Public Health, and the Alabama Medical Cannabis Patient Registry System maintained by the Alabama Medical Cannabis Commission. Obtaining this permit requires the physician to: complete an application.

Patients 52

Patients DEA Dispensary Conditions 52

Canna Law Blog

FEBRUARY 9, 2024

One of the most unexplainable and continuously disproven series of laws that the DEA have enforced for decades is the illogical Controlled Substances List. While any social media post from the DEA probably wouldn’t be met with overwhelming praise, this post was particularly ill-timed. Worse even, both George H.W. Of course we did.”

History 82

History DEA Policy Media 82

NORML

MARCH 1, 2019

” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .”

DEA 172

DEA Research and Development Clinical Trials Marijuana 172

Canna Law Blog

NOVEMBER 8, 2023

As I’m sure all of our readers are aware, the Department of Health and Human Services (HHS) apparently made a recommendation to DEA to move cannabis to Schedule III of the CSA recently. I say “apparently” because HHS’s letter to DEA is redacted to the point of uselessness.

Legalization 93

Legalization DEA Banking Cannabis 93

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . The manufacture methods of MDMA at a laboratory scale were originally placed in the public domain by Alexander Theodore Shulgin, Ph.D., ABOUT MAPS PUBLIC BENEFIT CORPORATION (MAPS PBC) .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. will top $1.9

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

NORML

JANUARY 17, 2019

As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision.

Clinical Trials 234

Clinical Trials Legislation DEA Strains 234

The Blunt Truth

OCTOBER 29, 2020

Oregon Senators voice their opposition to the DEA’s hemp rule. The public comment period runs from November 10, 2020 through January 11, 2021. dea hemp rule. Two weeks ago, we reported that the hemp industry was unhappy with the DEA’s new hemp rule. Five states have marijuana on the ballot this year.

DEA 116

DEA Hemp Extraction Food 116

Veriheal

AUGUST 23, 2023

A disputable new social media drug reporting bill believes that social media companies should screen client posts and report any drug-related exercises to the DEA. As they work to enhance public safety, elected officers should live unwavering in their obligation to staunchly defend the proper privacy and freedom of expression online.

Media 52

Media DEA Advocacy Legislation 52